Indications
Treatment of platinum sensitive relapsed (PSR) ovarian cancer
Composition
- Active substance
- cediranib maleate
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zemfirza
- Active substance
- cediranib maleate
- ATC code
- L01XE32
- Therapeutic area
- Ovarian Neoplasms
- Marketing authorisation holder
- AstraZeneca AB
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/004003